Ina K.
- Country
- Germany
- Department
- III. Medizinische Klinik und Poliklinik Nephrologie, Rheumatologie und Endokrinologie
Research Overview
- Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Dose Levels of ESK-001 in Adult Patients with Systemic Lupus Erythematosus
Data & Insights
Has run more than one trial at 70 of 167 partner sites.
Specializations
Autoimmune Disorders
The investigator specializes in the management of complex systemic autoimmune conditions, with particular focus on treatments for systemic lupus erythematosus and Sjögren's Syndrome.
- Systemic Lupus Management
- Sjögren's Syndrome Treatment
- Novel Therapeutic Approaches
Conducts research in innovative therapeutic interventions for systemic manifestations of autoimmune disorders.
Rheumatological Conditions
Focused on advancing treatment options for systemic sclerosis, investigating subcutaneous administration methods and their impact on skin sclerosis manifestations.
- Skin Sclerosis Treatment
- Systemic Sclerosis Management
- Subcutaneous Therapy Development
Explores innovative approaches in treating progressive rheumatological conditions.
Hematological Disorders
Specializes in the treatment of Hypereosinophilic Syndrome (HES), investigating novel therapeutic approaches for patients with uncontrolled disease states.
- HES Management
- Standard of Care Enhancement
- Treatment Resistance
Develops therapeutic strategies for complex hematological conditions requiring specialized intervention.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.